Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1.
Evan CantorAshley MeyerStephanie M MorrisJudith L Z WeisenbergNicole M BrossierPublished in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2022)
Selumetinib may have promise in epilepsy management in other children with NF1 or LGG.